These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 7425449)
1. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]. Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449 [TBL] [Abstract][Full Text] [Related]
2. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)]. Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528 [TBL] [Abstract][Full Text] [Related]
3. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)]. Neumann E Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134 [TBL] [Abstract][Full Text] [Related]
4. Pediatric Hodgkin's disease. Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P]. Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834 [TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)]. Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500 [No Abstract] [Full Text] [Related]
8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578 [TBL] [Abstract][Full Text] [Related]
9. [Polychemotherapy of Hodgkin's disease (author's transl)]. Jacquillat CL; Weil M; Auclerc G; Delbrück H; Chastang CL; Chelloul N; Boiron M; Bernard J Dtsch Med Wochenschr; 1975 Apr; 100(15):785-90. PubMed ID: 1122828 [TBL] [Abstract][Full Text] [Related]
10. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease]. Aghai E; Kende G; Many A; Ramot B Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045 [No Abstract] [Full Text] [Related]
12. [Possibilities of treatment of reduction in Hodgkin's disease. III. Can polychemotherapy when combined with radiotherapy of localised stages be reduced? (author's transl)]. Teillet F; Delbrück H; Bayle-Weisgerber C; Asselain B; Lelièvre P; Bernard J Dtsch Med Wochenschr; 1981 May; 106(18):566-70. PubMed ID: 7215184 [TBL] [Abstract][Full Text] [Related]
13. [Hodgkin's disease in childhood: long term results]. Cramer P; Schaison G; Andrieu JM; Boiron M; Bernard J Arch Fr Pediatr; 1982 Apr; 39(4):223-9. PubMed ID: 6896975 [TBL] [Abstract][Full Text] [Related]
14. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients]. Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520 [No Abstract] [Full Text] [Related]
15. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487 [TBL] [Abstract][Full Text] [Related]
16. [The results of radiotherapy managements in Hodgkin's disease (author's transl)]. Duchamp C; Clément R; Juin P J Radiol Electrol Med Nucl; 1977 May; 58(5):335-42. PubMed ID: 886527 [TBL] [Abstract][Full Text] [Related]
17. [Effect of combined chemotherapy on the prognosis of Hodgkin's disease: retrospective study of 74 cases from 1959-1973]. Walser A; Alberto P Schweiz Med Wochenschr; 1977 Apr; 107(16):569-77. PubMed ID: 67638 [TBL] [Abstract][Full Text] [Related]
18. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
19. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [TBL] [Abstract][Full Text] [Related]